Kim Corace

Dr. Kimberly Corace, PhD, CPsych is a Canadian psychiatrist based in Ottawa, Ontario.

Corace received her Ph.D. in Clinical Psychology from York University in 2008.¹⁾

Corace is the Vice President of Innovation and Transformation at The Royal Ottawa Health Care Group and a Clinical Investigator with the Royal's Institute of Mental Health Research.²⁾

Corace is an Associate Professor in the Department of Psychiatry at University of Ottawa.³⁾

Corace is an Adjunct Research Professor at Carleton University.⁴⁾

Corace is a founding member of the CAN-Change Network (Canadian Network for Health Behavior Change and Promotion).⁵⁾

Corace is a member of the Behavioural Science Working Group of the Ontario COVID-19 Science Advisory Table.⁶⁾

Corace is the president of the Canadian Psychological Association.⁷⁾

Corace is a member of the Communication Initiative Network, a group “convening the communication and media development, social and behaviour change community.”⁸⁾

The network is affiliated with Article 19, BBC Media Action, Communication for Social Change Consortium, the Department of International Development (now the Foreign, Commonwealth & Development Office), DW Akademie, Food and Agriculture Organization, Ford Foundation, Inter-American Development Bank, International Center for Research on Women (ICRW), International Development Research Centre, International Media Support, Johns Hopkins Bloomberg School of Public Health, Joint United Nations Programme on HIV and AIDS (UNAIDS), Open Society Foundations, Oxfam Novib, Pan American Health Organization, Rockefeller Foundation, Save the Children, Southern Africa AIDS Dissemination Service (SAfAIDS), Swiss Agency for Development and Cooperation, UNICEF, United Nations Development Programme (UNDP), United Nations Population Fund, United States Agency for International Development (USAID), University of Guelph, Wellcome Trust, and the World Health Organization (WHO).^{9) 10)}

Corace's areas of research interest include the evaluation of multidisciplinary models of hepatitis C care, mental health and substance use issues as barriers to hepatitis C treatment, stigma, treatment readiness and adherence, motivators and barriers for vaccine uptake.¹¹⁾

Her work also focuses on health behaviour change, including how behaviour change theories can be used to guide and inform novel interventions to facilitate health behaviour change (i.e., healthcare worker vaccination uptake and hand hygiene adherence) as well as the implementation of evidence into healthcare practice. In response to the COVID-19 pandemic, her research is currently exploring the mental health and substance use impacts of COVID-19 on people with pre-existing mental health and substance use problems, as well as the impact of changes in service provision and care delivery due to COVID-19.

Corace is part of a vaccine working group associated with the International COVID-19 Awareness and Responses Evaluation Study (iCARE), funded by the Canadian Institutes of Health Research (CIHR).¹²⁾

Corace has received funding from the Canadian Institutes of Health Research (CIHR) and the Canadian Centre on Substance Use and Addiction (CCSA).^{13) 14)}

She has received various forms of funding from Janssen, Novo Nordisk, Reckitt Benckiser, and Vertex Pharmaceuticals.^{15) 16)}

• https://ottawacitizen.com/news/local-news/new-eastern-ontario-service-to-streamline-simplify-access-to-mental-health-addictions-care